secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001104659-24-087838
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio reports 97.2% of public warrants and 69% of private warrants tendered in exchange offer
--------------------------------------------------------------------------------

- 6,703,428 public warrants (~97.2%) and 4,080,580 private placement warrants (~69.0%) validly tendered; settlement expected by Aug 12, 2024.
- Each tendered warrant exchanged for 0.30 Class A ordinary shares; remaining untendered warrants to be converted into 0.27 shares (10% less).
- Consents received to amend warrant agreement; post-offer exchange will eliminate all outstanding IPO warrants.
- Cantor Fitzgerald acted as dealer manager; Alliance Advisors as information agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924087838/0001104659-24-087838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924087838/tm2421034d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-087838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer